In cancers that CXCL13 harbor unfavorable prognosis, such as KIRC, intratumoral CXCL13 + CD8 + T cell infiltration determines poor clinical outcomes and immunoevasive contexture (27). This evidence concerns the gene CXCL13 and cancer.